These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
713 related items for PubMed ID: 17296463
1. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects. Marier JF, Ducharme MP, DiMarco M, Di Spirito M, Morelli G, Tippabhotla SK, Badri N, Rampal A, Monif T. Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463 [Abstract] [Full Text] [Related]
2. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers. Galan-Herrera JF, Poo JL, Rosales-Sanchez O, Fuentes-Fuentes E, Cariño L, Burke-Fraga V, Namur S, Parra MG. Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138 [Abstract] [Full Text] [Related]
3. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. Alkhalidi BA, Tamimi JJ, Salem II, Ibrahim H, Sallam AA. Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838 [Abstract] [Full Text] [Related]
4. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions. Spínola AC, Almeida S, Filipe A, Neves R, Trabelsi F, Farré A. Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489 [Abstract] [Full Text] [Related]
7. Pharmacokinetics of a once-daily extended-release formulation of pramipexole in healthy male volunteers: three studies. Jenner P, Könen-Bergmann M, Schepers C, Haertter S. Clin Ther; 2009 Nov; 31(11):2698-711. PubMed ID: 20110012 [Abstract] [Full Text] [Related]
11. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults. Swearingen D, Pennick M, Shojaei A, Lyne A, Fiske K. Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285 [Abstract] [Full Text] [Related]
12. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers. Kim BH, Shin KH, Kim J, Lim KS, Kim KP, Kim JR, Cho JY, Shin SG, Jang IJ, Yu KS. Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017 [Abstract] [Full Text] [Related]
13. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study. Chen L, Jiang X, Huang L, Lan K, Wang H, Hu L, Ren J, Li X, Zou Q. Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895 [Abstract] [Full Text] [Related]
18. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects. Henney HR, Shah J. Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289 [Abstract] [Full Text] [Related]